PHARMS
LIVE

Serial Number

98668118

Owner

Bioplantos Pharmalabs LLC

Attorney

David S. Taylor

First Use Date

Nov 4, 2024

Filing Date

Jul 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PHARMS Trademark

Serial Number: 98668118 • Registration: 8265352

PHARMS is a trademark filed by Bioplantos Pharmalabs LLC on July 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Bioplantos Pharmalabs LLC

502 S MacDill Ave
Tampa, FL 33609

Entity Type: 16

Trademark Details

Filing Date

July 26, 2024

Registration Date

May 19, 2026

First Use Anywhere

November 4, 2024

First Use in Commerce

November 4, 2024

Published for Opposition

June 3, 2025

Goods & Services

Dietary supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 19, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 19, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 30, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 30, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 28, 2026 SUPC
USE AMENDMENT FILED
Dec 4, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 4, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 13, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 12, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2025 NWOS
NEW APPLICATION ENTERED
Jul 26, 2024 NWAP